A staff member sorts medicines at a pharmacy in Huai ‘an, China on Dec. 10, 2022. CFOTO | Future Publishing | Getty Images A new antiviral pill for Covid was found to be as effective as Paxlovid at curbing mild to moderate illness among people at high risk of severe […]
Promising
TYK2 Inhibition Promising in Psoriatic Arthritis
The oral tyrosine kinase 2 inhibitor deucravacitinib was effective for the treatment of active psoriatic arthritis in a phase II placebo-controlled trial. At week 16, only 31.8% of patients who had been randomized to receive placebo met the 20% response criteria of the American College of Rheumatology (ACR20), compared with […]